InsideArbitrage Event Driven Monitor – June 30, 2023

Subscribe to receive our Event Driven Monitor by email every morning before the market opens.

Merger Arbitrage

1. SGTX: Sigilon Therapeutics (SGTX) to be acquired by Eli Lilly and Company (LLY) for $34.6 million or $14.92 per share in cash plus one non-tradeable contingent value right (“CVR”) per share that entitles the holder to receive up to an additional $111.64 per share in cash, for a total potential consideration of up to $126.56 per share in cash without interest.
2. INDT: Centerbridge Partners complete the acquisition of INDUS Realty Trust.
3. VECT: Ironwood Pharmaceuticals (IRWD) and VectivBio Holding AG (VECT) announced the successful completion of the tender offer.

Only plus or premium subscribers can access this post. Subscribe today.